Read + Share
Falkevall A, Mehlem A, Folestad E, Ning FC, et al. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease
development by targeting lipolysis in the white adipose tissue. J Hepatol 2023;78:901-913.
PMID: 36717026
|
 |
|
Falkevall A, Mehlem A, Folestad E, Ning FC, et al. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease
development by targeting lipolysis in the white adipose tissue. J Hepatol 2023;78:901-913.
PMID: 36717026
|
|
|
|